MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Orchid Chemicals and Pharmaceuticals
Orchid Chemicals and Pharmaceuticals
BSE: 524372|NSE: ORCHIDCHEM|ISIN: INE191A01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 28, 17:00
124.30
1.55 (1.26%)
VOLUME 468,406
LIVE
NSE
May 28, 17:00
124.30
1.75 (1.43%)
VOLUME 928,321
Management Interviews on Orchid Chemicals and Pharmaceuticals
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Orchid Chem to repay FCCB through ECB, borrows $100 mn 

10.51 am | 19 Dec 2011 |  Source: CNBC-TV18

K Raghavendra Rao, chairman and managing director, Orchid Chemicals spoke to CNBC-TV18 about the fund-raising the company has undertaken and strategie...

Can beat FY12 guidance if exchange rate holds: Orchid Chem 

4.34 pm | 01 Nov 2011 |  Source: CNBC-TV18

Orchid Chemicals reported its second quarter results for FY11. The drug company posted a net profit at Rs. 23.4 crore for the quarter ended September ...

Operations not impacted by fire at Chennai lab: Orchid Chem 

12.25 pm | 26 Sep 2011 |  Source: CNBC-TV18

In an interview to CNBC-TV18, K Raghavendra Rao, managing director of Orchid Chemicals & Pharmaceuticals Ltd, said a fire took place last morning in o...

Orchid Chem in bad state, may fund debt with another one 

12.18 pm | 30 Aug 2011 |  Source: CNBC-TV18

Orchid Chemicals seems to be in a bad situation. K Raghavendra Rao, managing director, Orchid Chemicals & Pharmaceuticals is concerned that raising eq...

No impact on margin until share price halves: Orchid Chem 

10.47 am | 23 Jun 2011 |  Source: CNBC-TV18

K Raghavendra Rao, MD of Orchid Chemicals & Pharmaceuticals, in an interview with CNBC-TV18’s Udayan Mukherjee and Mitali Mukherjee, said that unless ...

Orchid Chem hopes to maintain EBIDTA margin at 24% in FY12  

4.36 pm | 18 May 2011 |  Source: CNBC-TV18

In an interview with CNBC-TV18, Raghavendra Rao, Orchid Chemicals says, the company is guiding 25% growth in the top-line and more than proportionate ...

Expect to better rev guidance by 10%: Orchid Chem 

10.55 am | 21 Jan 2011 |  Source: CNBC-TV18

Speaking to CNBC-TV18, K Raghavendra Rao, MD, Orchid Chemicals expects to end FY11 with margins of 24% and also sees strong double digit growth in the...

1
Quick Links for Orchid Chemicals and Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.